Ben Krishna News Today

Vaccination and natural immunity have dramatically reduced the death toll from COVID-19, but catching COVID-19 for a third time is still no walk in the park, as Linda Geddes discovered last week.

Referrals to Cambridge's long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the successful rollout of the vaccine.

The only Omicron sub-variant with its own name may become the next globally dominant strain of COVID-19. The so-called Centaurus strain, which is scie

A new COVID variant, BA.2.75, has been detected in the UK and several other countries. But the data we have at the moment doesn’t suggest there’s any reason to panic.

CASES of a new Covid variant which has spread rapidly in India have been identified in Scotland.

New variants which have mutations that evade our immunity will replicate and spread, leading to waves of infections

Intuitively, we would assume that subsequent infections should be less severe. But this won’t always be the case.

Hydroxychloroquine, the anti-malaria drug controversially touted as a cure for COVID despite a lack of robust evidence, is creating renewed interest as a

Ben Krishna is a postdoctoral research fellow at the University of Cambridge, specialising in virology and immunology. He began researching Human Cytomegalovirus disease in patients receiving stem cell transplants, but his research now focuses on the immunology of Covid-19 and, in particular, 'long Covid'.

From Alpha to Omicron, the SARS-CoV-2 Virus has slammed the human species for now three years, but the end is near, bar a worse mutation while Omicron infects billions.